NCT05171036

Brief Summary

A fall in the elderly is defined by the WHO as "an event in which a person \[over 65 years of age\] inadvertently falls to a lower level on the ground or other surface than they were previously at". The severity of the consequences of falls is correlated with the age of the person who suffers them, making people over 65 at risk. Since 2000, the number of falls among the elderly has not decreased, including in institutions. Today, the direct and indirect costs of falls are estimated at 1.7 billion euros in France. The French National Authority for Health (HAS) stresses that the lack of success of prevention policies is due in particular to the lack of evaluation and prevention resources. In nursing homes, this lack of resources is sometimes used to justify passive restraint to ensure the safety of participants. However, this method poses the problem of the free movement of residents within the institution. The fall detection technologies already on the market do not allow for the assessment of the risk of falling and therefore for early action. Based on the latest scientific data in static posturography, researchers at the Borelli Centre have developed posturographic markers whose non-linear analysis makes it possible to establish an objective and clinically relevant score based on the study of the displacement of the centre of pressure. In contrast to the techniques commonly used in the laboratory to study balance (which are not usable in health care institutions because of their cost, lack of transportability and the expertise required to explore the recorded data), this method of measurement allows health care professionals to quickly and easily measure the balance of participants in routine consultations. Thus, special attention and targeted rehabilitation can then be implemented to prevent falls and their consequences.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
348

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 28, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

January 17, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

December 28, 2021

Status Verified

December 1, 2021

Enrollment Period

1 month

First QC Date

November 25, 2021

Last Update Submit

December 27, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Predictive value of indicators measured monthly over the 6 months of follow-up

    Predictive value of indicators measured monthly over the 6 months of follow-up (3 months without ABS followed by 3 months with ABS). The predictive value will be quantified by an evaluation of the threshold of the predictive score out of 100, based on a minimum sensitivity of 80% and a maximum specificity (the Youden index is the numerical criterion), via an ROC curve and a measurement of the area under the curve (AUC) for the classification between "at high risk of falling" and "at low risk of falling" (binary criterion). This classification is subsequently verified by means of the falls collection sheets and the falls history at the next visit.

    Every 6 months

Secondary Outcomes (2)

  • Positive (PPV) and Negative (NPV) predictive values based on the binary classification "high risk of falling" and "low risk of falling".

    Every 6 months

  • Correlation of fall risk indicators with other recorded variables

    Every 6 months

Other Outcomes (1)

  • Acceptability of the measure system

    At 24 months

Study Arms (1)

Institutionalized elderly people undergoing adapted physical activity

EXPERIMENTAL

2h/week for 3 months (i.e. 24 sessions), after 3 months of no-APA for gait and balance baseline recordings, with the rehabilitation team in place in the establishments, around the 4 specific programmes

Other: Adapted Physical Activity

Interventions

* Group 1 Maintenance of autonomy: "Patients in group 1 have no cardiovascular disorders, possibly some cognitive deficits but do not reside in a protected unit. * Group 2 Prevention of the risk of falls: "Patients in group 2 have no cardiovascular problems, possibly some cognitive problems, but can finally follow the indications of the cognitive assessment in the form developped for the study. * Group 3 Prevention of the risk of falls and monitoring of cardiovascular disorders in the absence of cognitive impairment: "Patients in group 3 have had a recent, and currently stabilised, cardiovascular event that may justify exercise reconditioning. * Group 4 Prevention of the risk of falls and disorientation in a context of cognitive deficit: "Patients in group 4 have moderate to severe cognitive disorders, or have Alzheimer's disease or a related disease at a stage of the disease requiring special attention.

Institutionalized elderly people undergoing adapted physical activity

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Adult subjects of both sexes, aged 65 and over, with social insurance;
  • Residing in an ORPEA Group retirement home;
  • Do not have a neurological, inner ear or visual disorder that is incompatible with climbing on the force platform or walking 10 metres round trip without human assistance;
  • Can safely climb onto the platform by force (as estimated by the investigating practitioner) and can maintain an erect position for more than 1 minute, with eyes open or closed;
  • Had an MMSE score of more than 18 on the nursing home entrance examination;
  • Having a life expectancy of more than 6 months, as estimated by the coordinating doctor;
  • Having signed the informed consent.
  • Non-mobile resident: any person with a musculoskeletal or neurosensory disorder that does not allow them to stand for more than 1 minute on the power platform;
  • History of limb amputation;
  • Blindness, assessed using an Amsler grid;
  • Refusal of the resident.

You may not qualify if:

  • Exit from the trial by resident's choice ;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Quijoux F, Bertin-Hugault F, Zawieja P, Lefevre M, Vidal PP, Ricard D. Postadychute-AG, Detection, and Prevention of the Risk of Falling Among Elderly People in Nursing Homes: Protocol of a Multicentre and Prospective Intervention Study. Front Digit Health. 2021 Jan 27;2:604552. doi: 10.3389/fdgth.2020.604552. eCollection 2020.

    PMID: 34713067BACKGROUND
  • Quijoux F, Vienne-Jumeau A, Bertin-Hugault F, Zawieja P, Lefevre M, Vidal PP, Ricard D. Center of pressure displacement characteristics differentiate fall risk in older people: A systematic review with meta-analysis. Ageing Res Rev. 2020 Sep;62:101117. doi: 10.1016/j.arr.2020.101117. Epub 2020 Jun 19.

    PMID: 32565327BACKGROUND
  • Dot T, Quijoux F, Oudre L, Vienne-Jumeau A, Moreau A, Vidal PP, Ricard D. Non-Linear Template-Based Approach for the Study of Locomotion. Sensors (Basel). 2020 Mar 30;20(7):1939. doi: 10.3390/s20071939.

    PMID: 32235667BACKGROUND

MeSH Terms

Conditions

Gait Disorders, NeurologicMotor Activity

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Flavien QUIJOUX, PhD

    Orpea Group

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Flavien Quijoux, PhD

CONTACT

Francois Bertin-Hugault, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2021

First Posted

December 28, 2021

Study Start

January 17, 2022

Primary Completion

February 28, 2022

Study Completion

December 1, 2023

Last Updated

December 28, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will share

The clinical trial data will be aggregated and presented as averages by group and subgroup in order to comply with the regulatory authorities in the treatment of so-called sensitive data, particularly in relation to the health and identity of the persons involved in the research. Scientific publications concerning the protocols, methods of analysis of the data used and the results of the study will be submitted to peer-reviewed journals and/or code-sharing platforms to promote reproducible and transparent science.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
2021 - Publication of the Protocole 2022 - Publication of the preliminary results 2023/24 - Publication of the final results